PharmaLex

PharmaLex, a key entity within AmerisourceBergen, operates as a global healthcare leader focused on end-to-end product commercialization and pharmaceutical distribution. Founded in 1998, the company excels in guiding clients through intricate global market access strategies, aiming to improve patient outcomes worldwide. PharmaLex's specialized services cater to the pharma, biotech, and medtech sectors, providing end-to-end support from initial strategic planning and non-clinical requirements through clinical development, regulatory submission processes, and comprehensive post-approval/maintenance activities. Leveraging technology-elevated solutions, PharmaLex ensures robust compliance and efficiency across the entire product lifecycle.

With a substantial workforce of 1,000-5,000 employees distributed across 7 global locations, PharmaLex offers deep expertise in navigating complex regulatory environments. Their service suite includes critical areas such as development consulting, regulatory affairs, pharmacovigilance, quality management systems (QMS), and clinical data management. Meet PharmaLex's team to discover the professionals dedicated to advancing healthcare solutions. The company's commitment to scientific rigor and adherence to standards like GMP are central to its operations.

PharmaLex's strategic integration with AmerisourceBergen enhances its capacity to deliver innovative therapies and medical technologies to patients globally. By focusing on specialized services and maintaining a high standard of compliance and quality, PharmaLex plays a vital role in the successful market entry and sustained presence of life science products. Their approach ensures clients can effectively manage their product portfolios and contribute to healthier futures.